![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2023/06/notogen.jpg)
Notogen, Inc.
The basis of Notogen’s initial technology is the study of the conditions sustained by the presence of notochordal cells in the spinal disc. Notogen has identified a compound that preserves critical cells and can mediate degeneration and inflammation while promoting the presence of healthy disc tissues in laboratory in vitro and in vivo models.